School of Optometry 眼科視光學院
Home About Us What's New Subscribe eNewsletter Contact Us My School 繁體 简体 Text Only Print
About us
Message from Head of School
Vision & Mission
Our People
Academic Staff
Affiliate Faculty Members
Honorary & Adjunct Professor
Visiting Staff & Academic Visitors
Optometry Clinic Staff
Research Staff
Research Students
Our Research
About us > Our People > Academic Staff > Dr Ellen TAN
Our People
Dr Henry CHAN | Dr Allen CHEONG | Prof. Pauline CHO | Dr Rachel CHUN | Dr Chi-wai DO | Dr Chea-su KEE | Prof. Carly LAM | Dr Andrew LAM | Dr Thomas LAM | Dr Jeffrey LEUNG | Dr Tina LIAN | Dr Bin LIN | Dr Jessica NEUVILLE | Dr Feng PAN | Dr Ellen TAN | Dr Patrick TING | Prof. Chi-ho TO | Dr Dennis TSE | Prof. George WOO | Prof. Maurice YAP

Dr Ellen TAN

Dr Ellen Shaoying TAN
PhD
Research Assistant Professor

ORCiD 0000-0001-9997-7396
Author ID (Scopus) 56789364900

Biographical Sketch

Dr Tan obtained a Bachelor’s degree in clinical medicine from Xiangya Medical School, Central South University, China, in 2010. She then completed her MSc and PhD degrees at the Department of Ophthalmology and Visual Sciences, The Chinese University of Hong Kong, in 2011 and 2014 respectively. From 2015 to 2017, Dr Tan was a Postdoctoral Clinician Researcher at the Department of Ophthalmology, Chinese People’s Liberation Army General Hospital. From 2018 to 2020, she worked as an Associate Consultant in Ophthalmology in Joint Shantou International Eye Center of Shantou University and The Chinese University of Hong Kong, China. Dr Tan joined the School of Optometry of The Hong Kong Polytechnic University in 2020 as a Research Assistant Professor.

In addition to the diagnosis and treatment of common diseases in ophthalmology, Dr Tan is an expert in glaucoma and neuro-ophthalmic diseases. She has provided clinical service to thousands of ophthalmological patients every year. She also joined several poverty alleviation projects, including a charity programme for cataract screening and operations in rural areas, and a training programme under the Lifeline Express Foundation.

Dr Tan’s research interests include pathogenesis, clinical features, and therapeutic strategy on autoimmune optic neuropathy, non-arteritic anterior ischaemic optic neuropathy, primary angle closure glaucoma, intraocular pressure measurement, and intraocular pressure fluctuation in glaucoma.

Dr Tan was awarded the Tsutsui-Fujino International Prize and Scholarship in the 56th Annual Meeting of the Japanese Neuro-ophthalmology Society (2018), the Achievement Award in the 33rd Asia-Pacific Academy of Ophthalmology Congress (2018), and Prof. Yasuo Tano Travel Grant in the 32nd Asia-Pacific Academy of Ophthalmology Congress (2017). She is an Editor of the Journal of Neuro-Ophthalmology (Chinese Version), and the President of the Youth Committee of Neuro-Ophthalmology Society of the Chinese Research Hospital Association.

Selected Publications

  1. Song H, Zhou H, Yang M, Tan S, Wang J, Xu Q, Liu H, Wei S. Clinical characteristics and prognosis of myelin oligodendrocyte glycoprotein antibody-seropositive paediatric optic neuritis in China. Br J Ophthalmol. 2019;103(6):831-836.
  2. Zhao Y, Tan S (Co-first author), Chan CY, Xu Q, Zhao J, Teng D, Fu H, Wei S. Clinical features of demyelinating optic neuritis with seropositive myelin oligodendrocyte glycoprotein antibody in Chinese patients. Br J Ophthalmol. 2018;102(10):1372‐1377.
  3. Tan S, Baig N, Hansapinyo L, Jhanjil V, Wei S, Tham CC. Comparison of self-measured diurnal intraocular pressure profiles using rebound tonometry between primary angle closure glaucoma and primary open angle glaucoma patients. PLOS ONE. 2017, 23;12(3):e0173905. doi: 10.1371/journal.pone.0173905. eCollection 2017.
  4. Tan S, Yu M, Baig N, Hansapinyo L, Tham CC. Agreement of patient-measured intraocular pressure using rebound tonometry with Goldmann applanation tonometry (GAT) in glaucoma patients. Sci. Rep. 2017, 7, 42067; doi: 10.1038.
  5. Tan S, Yu M, Baig N, Chan PP, Tang FY, Tham CC. circadian intraocular pressure fluctuation and disease progression in primary angle closure glaucoma. Invest Ophthalmol Vis Sci. 2015;56(8):4994-5005.